According to XBiotech's latest financial reports the company's current EPS (TTM) is -HK$7.31. In 2022 the company made an earnings per share (EPS) of -HK$8.40 a decrease over its 2021 EPS that were of -HK$4.51.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -HK$7.37 | -12.2% |
2022 | -HK$8.40 | 86.21% |
2021 | -HK$4.51 | 48.57% |
2020 | -HK$3.03 | -102.27% |
2019 | HK$133.48 | -3060.34% |
2018 | -HK$4.51 | -41.41% |
2017 | -HK$7.70 | -39.26% |
2016 | -HK$12.67 | 37.46% |
2015 | -HK$9.22 | 73.13% |
2014 | -HK$5.32 |